Mixed Results for Gilead Sciences' COVID-19 Treatment

Motley Fool

23 May 2020 0 shares 1 views

Motley Fool

Published 23 May 2020

Remdesivir helped patients recover faster, but the experimental coronavirus treatment didn't lower patients' risk of death.